San Diego’s Tandem Diabetes Care inked a European distribution deal with Rubin Medical, meaning its insulin pumps will be sold outside the U.S. for the first time.
Through the agreement Tandem’s t:slim X2 insulin pump, insulin cartridge and family of infusion sets will be offered in Sweden, Norway and Denmark. The company in a news release called it a “significant step forward for our international commercialization strategy.”
Under the arrangement Sweden-based Rubin Medical will perform sales, marketing and customer training and support for Tandem’s products. Timing for the availability of Tandem products in Sweden, Norway and Denmark has not been announced.
Tandem recently closed a $69 million public stock offering.